Skip to main navigation Skip to search Skip to main content

Targeting hyperinflammation in infection: can we harness the COVID-19 therapeutics momentum to end the dengue drugs drought?

  • Angela McBride
  • , Puja Mehta
  • , Laura Rivino
  • , Athimalaipet V Ramanan
  • , Sophie Yacoub*
  • *Corresponding author for this work

Research output: Contribution to journalComment/debate (Academic Journal)peer-review

11 Citations (Scopus)

Abstract

[No abstract]
Original languageEnglish
Pages (from-to)e277-e278
JournalThe Lancet Microbe
Volume2
Issue number7
Early online date20 Apr 2021
DOIs
Publication statusPublished - 1 Jul 2021

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • COVID-19
  • Dengue/drug therapy
  • Droughts
  • Humans
  • SARS-CoV-2

Fingerprint

Dive into the research topics of 'Targeting hyperinflammation in infection: can we harness the COVID-19 therapeutics momentum to end the dengue drugs drought?'. Together they form a unique fingerprint.

Cite this